Literature DB >> 14769399

Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats.

S Shoham1, C Bejar, E Kovalev, M Weinstock.   

Abstract

It has been reported that intracerebroventricular (icv) injection of streptozotocin (STZ) impairs spatial memory by disrupting glucose utilization through an insulin-dependent mechanism in the cerebral cortex and hippocampus. However, evidence of septal damage and microglosis induced by icv STZ suggested that its neurotoxic effects could contribute to the memory impairment. The present study examined the histopathological changes in adult rats following three icv STZ injections (0.25 mg into each lateral ventricle) and their effects on spatial memory in a Morris water maze task. STZ retarded acquisition of reference learning (progressive reduction in escape latency) and disrupted working memory (difference in escape latency between the two swims within a daily session). STZ caused selective injury to myelin and axons in the fornix and hippocampus in association with activation of microglia. The 3rd ventricle was enlarged by 100-150% because of a loss of ependymal cells and damage to hypothalamic periventricular myelin but the process involved in these changes is unclear. Our findings provide an alternative explanation for the decrease in glucose utilization in the hippocampus and cortex and the impairment of spatial memory induced by STZ. These could result from a disruption of the communication through myelinated axons in the fornix connecting the septum and the hippocampus, and through other myelinated axons adjacent to the ventricles. The selective damage to myelin may well result from oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14769399     DOI: 10.1016/j.expneurol.2003.08.015

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  35 in total

Review 1.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

Review 2.  JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities.

Authors:  Sidharth Mehan; Harikesh Meena; Deepak Sharma; Rameshwar Sankhla
Journal:  J Mol Neurosci       Date:  2010-09-28       Impact factor: 3.444

Review 3.  Models and mechanisms for hippocampal dysfunction in obesity and diabetes.

Authors:  A M Stranahan
Journal:  Neuroscience       Date:  2015-04-28       Impact factor: 3.590

Review 4.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

5.  Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia.

Authors:  Puneet Rinwa; Baljinder Kaur; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-06       Impact factor: 3.000

6.  Effects of active constituents of Crocus sativus L., crocin on streptozocin-induced model of sporadic Alzheimer's disease in male rats.

Authors:  Mohsen Khalili; Faezeh Hamzeh
Journal:  Iran Biomed J       Date:  2010 Jan-Apr

7.  Vitamin D3 attenuates cognitive deficits and neuroinflammatory responses in ICV-STZ induced sporadic Alzheimer's disease.

Authors:  P Yamini; R S Ray; Kanwaljit Chopra
Journal:  Inflammopharmacology       Date:  2017-07-12       Impact factor: 4.473

8.  Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?

Authors:  A Knezovic; A Loncar; J Homolak; U Smailovic; J Osmanovic Barilar; L Ganoci; N Bozina; P Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2017-05-03       Impact factor: 3.575

9.  Functional Deficits Precede Structural Lesions in Mice With High-Fat Diet-Induced Diabetic Retinopathy.

Authors:  Rithwick Rajagopal; Gregory W Bligard; Sheng Zhang; Li Yin; Peter Lukasiewicz; Clay F Semenkovich
Journal:  Diabetes       Date:  2016-01-06       Impact factor: 9.461

10.  Protective effects of evodiamine in experimental paradigm of Alzheimer's disease.

Authors:  Dongmei Wang; Chenying Wang; Ling Liu; Sanqiang Li
Journal:  Cogn Neurodyn       Date:  2018-01-25       Impact factor: 5.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.